MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients.
The Department for Business and Trade (DBT) has produced the Genomics Spotlight 2024 to showcase the UK’s expertise in genomics and the latest developments that make the UK a hub for genomics business and investment.
The Innovation in Life Sciences funding call seeks applications from organisations in the life sciences sector to create HNCDI projects that apply emerging digital technologies to industrially relevant and impactful research and innovation to further drug discovery and precision medicine in the UK.
The UK is a global leader in TechBio, drawing substantial investments and nurturing a vibrant ecosystem of talent and businesses, reveals a report launched today by the BIA.
